Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongsheng Yue

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Oxidative Medicine and Cellular Longevity|April 16, 2021
Bevacizumab-Induced Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and ERK Inactivation Contribute to CardiotoxicityYue Li, Wei Tian, Dongsheng Yue, et al.
Journal of Clinical Pathology|July 16, 2013
Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinomaHua Zhang, Jun Liu, Dongsheng Yue, et al.
Cancer Research and Treatment|November 23, 2021
The Role of Neutrophil-to-Lymphocyte Ratio in Predicting Pathological Response for Resectable Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemotherapy Combined with PD-1 Checkpoint InhibitorsXiaoyan Sun, Yingnan Feng, Bin Zhang, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 11, 2021
Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single CenterJianquan Zhu, Yu Zhang, Meng Wang, et al.
Thoracic Cancer|August 23, 2021
Tumor-associated macrophages (TAMs)-derived osteopontin (OPN) upregulates PD-L1 expression and predicts poor prognosis in non-small cell lung cancer (NSCLC)Yue Li, Hailin Liu, Yujie Zhao, et al.
International Journal of Medical Sciences|March 8, 2018
Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling PathwayJuanjuan Che, Dongsheng Yue, Bin Zhang, et al.
Plos One|May 8, 2015
Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort StudyHua Zhang, Lianmin Zhang, Kaikai Zhu, et al.
BMC Cancer|June 12, 2014
Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelinesDongsheng Yue, Liqun Gong, Jian You, et al.
Journal for Immunotherapy of Cancer|February 9, 2021
Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with <i>ROS1</i>-rearranged lung adenocarcinomaDongsheng Yue, Juanjuan Qian, Zhipeng Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 6, 2013
SMO expression level correlates with overall survival in patients with malignant pleural mesotheliomaYi Zhang, Jianxing He, Fang Zhang, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Oxidative Medicine and Cellular Longevity|April 16, 2021
Bevacizumab-Induced Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and ERK Inactivation Contribute to CardiotoxicityYue Li, Wei Tian, Dongsheng Yue, et al.
Journal of Clinical Pathology|July 16, 2013
Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinomaHua Zhang, Jun Liu, Dongsheng Yue, et al.
Cancer Research and Treatment|November 23, 2021
The Role of Neutrophil-to-Lymphocyte Ratio in Predicting Pathological Response for Resectable Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemotherapy Combined with PD-1 Checkpoint InhibitorsXiaoyan Sun, Yingnan Feng, Bin Zhang, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 11, 2021
Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single CenterJianquan Zhu, Yu Zhang, Meng Wang, et al.
Thoracic Cancer|August 23, 2021
Tumor-associated macrophages (TAMs)-derived osteopontin (OPN) upregulates PD-L1 expression and predicts poor prognosis in non-small cell lung cancer (NSCLC)Yue Li, Hailin Liu, Yujie Zhao, et al.
International Journal of Medical Sciences|March 8, 2018
Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling PathwayJuanjuan Che, Dongsheng Yue, Bin Zhang, et al.
Plos One|May 8, 2015
Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort StudyHua Zhang, Lianmin Zhang, Kaikai Zhu, et al.
BMC Cancer|June 12, 2014
Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelinesDongsheng Yue, Liqun Gong, Jian You, et al.
Journal for Immunotherapy of Cancer|February 9, 2021
Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with <i>ROS1</i>-rearranged lung adenocarcinomaDongsheng Yue, Juanjuan Qian, Zhipeng Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 6, 2013
SMO expression level correlates with overall survival in patients with malignant pleural mesotheliomaYi Zhang, Jianxing He, Fang Zhang, et al.
Pageof 6